Large-scale testing (Phase 3)Study completedNCT02577016
What this trial is testing
Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 141